<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04512222</url>
  </required_header>
  <id_info>
    <org_study_id>EARLY-MYO-AF</org_study_id>
    <nct_id>NCT04512222</nct_id>
  </id_info>
  <brief_title>EARLY-MYO-AF Registry</brief_title>
  <official_title>EARLY-MYO-AF (EARLY Integrated Therapies on MYOcardial Function Improvements in Patients With Atrial Fibrillation) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this registry is to depict the myocardial function improvement in AF patients&#xD;
      by integrated therapy and to assess the prognostic discrepancies of various intervention&#xD;
      modalities. Information will be collected prospectively in about 5000 AF patients. Subjects&#xD;
      will be followed for up to 3 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-centered, non-randomized, observational registry study of AF&#xD;
      patients that undergo radio-frequency catheter ablation, left atrial appendage occlusion or&#xD;
      surgical ablation. Information of other medication intervention and clinical outcomes are&#xD;
      also prospectively collected in the database. This project will establish a prospective&#xD;
      registry of 5000 AF patients with follow-ups of up to 3 years.&#xD;
&#xD;
      The aim of the project will be as following:&#xD;
&#xD;
        1. To investigate pathophysiological changes of both atrial and ventricular myocardial&#xD;
           function in AF patients.&#xD;
&#xD;
        2. To identify clinical indices (including baseline, comorbidities, medication or&#xD;
           operational interventions) that are associated with adverse clinical outcomes.&#xD;
&#xD;
        3. To spot potential therapeutical targets in the continuum of AF: from risk-factors&#xD;
           elimination to mortality and disability prevalence reduciton.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2012</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Major Adverse Cardiovascular Events</measure>
    <time_frame>3 years</time_frame>
    <description>A composite of stroke/transient ischemic attack, thromboembolism and all-cause mortality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>3 years</time_frame>
    <description>A composite of events listed below: a)Bleeding resulting in a decrease in hemoglobin of â‰¥2 g/dL or over a 24-hour period b) Bleeding leading to a transfusion of 2 or more units of packed red blood cells c) Bleeding that occurs in a critical site (intracranial, intraspinal, intraocular, pericardial, intra-articular, intramuscular with compartment syndrome or retroperitoneal) d. Bleeding that leads to death.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Atrial fibrillation event</measure>
    <time_frame>3 years</time_frame>
    <description>Documented Atrial fibrillation of more the 5 minutes duration.</description>
  </other_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Flutter</condition>
  <eligibility>
    <study_pop>
      <textblock>
        AF patients undergo interventional or surgical procedures are eligible for this registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible patients must be at least 18 years old at the time of enrollment.&#xD;
&#xD;
          -  Patients who are clinically indicated catheter ablation or other interventions (LAAC&#xD;
             or surgical maze procedure) for persistent or long standing persistent AF.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication for anticoagulation therapy&#xD;
&#xD;
          -  Another (non-AF) indication for long term anticoagulation&#xD;
&#xD;
          -  Patients who have been enrolled as a respondent on other clinical studies&#xD;
&#xD;
          -  Inability to attend scheduled, periodic office visits for follow-up&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patient has a life expectancy of less than 6 months due to any condition.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinhua Wang, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lingcong Kong, M.D.</last_name>
    <phone>008602168383164</phone>
    <email>avrilblanche373@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinhua Wang, Prof.</last_name>
      <phone>008602168383164</phone>
      <email>ttwwxh@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2020</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

